WA09 hESC (WiCell) and A04 hiPSC, a clonal derivative of HPSI0114i-kolf_2 [95 (link)], were provided by Dr. Bill Skarnes, JAX. Cells were maintained in StemFlex defined culture medium (Thermo Fisher Scientific, Waltham, MA, USA) as adherent cultures on a substrate of a recombinant fragment of human vitronectin (Synthemax, Corning, Corning, NY, USA). Cells were routinely passaged with a non-enzymatic dissociation reagent (ReLeSR, Stem Cell Technologies, Vancouver, CB, Canada). Cells were used within 15 passages from diploid master stocks, and undifferentiated cultures expressed cell surface markers and transcription factors characteristic of the pluripotent state. Bimonthly testing confirmed the absence of contamination by mycoplasma or other adventitious microbial agents. Human embryonic stem cell research was approved by the University of Connecticut Stem Cell Research Oversight Committee on behalf of JAX.
Free full text: Click here